Keenan Greg 4

What Happened

• Greg Keenan, SVP and Chief Medical Officer of Aurinia Pharmaceuticals (AUPH), had 8,069 shares withheld to satisfy tax withholding upon the vesting of restricted stock units (RSUs). The shares were valued at $14.32 each, for a total of approximately $115,548. This is a tax-withholding disposition, not an open-market sale or purchase.

Key Details

• Transaction date: 2026-03-06; Filing date: 2026-03-10 (timely — within two business days).
• Price per share: $14.32; Total value of shares withheld: ~$115,548.
• Transaction code: F (tax withholding); Footnote F1: shares withheld to satisfy tax withholding obligations upon RSU vesting.
• Shares owned after transaction: not specified in the provided Form 4 summary.
• This was not a market sale or purchase — shares were retained/forfeited to the company to cover taxes.

Context

• This is a routine tax-withholding event tied to RSU vesting (a form of compensation). Such withholding is administrative and generally does not indicate insider sentiment about the company's outlook. For investors tracking insider signals, open-market purchases tend to be more informative than withholding or other non-market dispositions.